Search Results 1561-1570 of 17121 for monoclonal antibody
... Antibody (ANCA) at 6 months. The study is a double-blind, randomized, active controlled phase 2 study. It will take place at multiple sites and enroll 30 ...
... antibody 6. History of clinically significant bleeding event within 30 days before the first dose of study drug or need for therapeutic anticoagulation on ...
... antibody. Patients must be at least 90 days since an autologous stem cell transplant, if performed. 3.1.5 Patients must have measurable disease per IMWG ...
Subject has received prior treatment with an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody-containing regimen for at least 2 ...
... antibodies, or positive result of Hep C polymerase chain reaction (PCR) analysis. The presence of COL7 antibodies in clinically significant titer by ...
tTG-IgA > 10x ULN, have had a positive celiac serology (i.e., DGP-IgG, DGP-IgA or EMA (endomysial antibody)- ... antibody test and hepatitis B virus ...
Titer for neutralizing antibodies (NAb) to AAV rh10 > [1:50] at Screening ... antibody (anti-HCV) or hepatitis B surface antigen (HBsAg); or who have ...
It works by causing your body to produce its own protection (antibodies) against the disease. Pneumococcal infection can cause serious problems, such as ...
... antibody (e.g., teclistamab), BCMA antibody directed conjugate (such as BLENREP), and BCMA-CAR-T (such as CARVYKT1TM); Subjects with adequate hematologic ...
Subjects with a positive test for Hepatitis C (HCV) antibody are excluded, regardless of viral load. If hepatitis C antibody is positive, confirmatory tests may ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.